Behavioral pharmacokinetics of marijuana

Area of Science:

• Pharmacology
• Neuroscience
• Traffic Safety

Background:

• Marijuana use is prevalent, and understanding its effects on cognitive and motor skills is crucial for public health and safety.
• Delta-9-tetrahydrocannabinol (THC) is the primary psychoactive component in marijuana, responsible for many of its effects.
• Assessing the impact of THC on performance relevant to driving is essential for road safety regulations.

Purpose of the Study:

• To investigate the relationship between plasma delta-9-tetrahydrocannabinol (THC) levels and performance decrements in perceptual-motor tasks related to driving.
• To determine the pharmacokinetic and pharmacodynamic covariation of THC in relation to driving impairment.

Main Methods:

• Male volunteers smoked marijuana cigarettes with varying doses of THC (100, 200, or 250 µg/kg).
• Performance on three driving-related perceptual-motor tasks was assessed over 24 hours post-smoking.
• Blood samples were collected to measure THC plasma concentrations (pharmacokinetics).

Main Results:

• A significant linear correlation was observed between tracking errors under divided attention and THC plasma levels (5-25 ng/ml) for approximately 2 hours.
• A sigmoid relationship was found between critical tracking breakpoint and log THC plasma levels (2-25 ng/ml) for approximately 7 hours.
• These findings indicate a dose- and time-dependent effect of THC on driving-related performance.

Conclusions:

• Plasma THC levels are a reliable indicator of impairment in specific driving-related tasks.
• THC significantly impairs perceptual-motor performance, with effects lasting for several hours post-consumption.
• This research highlights the importance of understanding THC pharmacokinetics and pharmacodynamics for assessing driving risks associated with marijuana use.